USPTO serial 79347601
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United States| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological services, namely, scientific research, analysis and testing in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; scientific research; scientific research services, namely, diagnostic services related to research; analysis of medicine, pharmaceuticals and vaccines of others to assure compliance with industry standards; industrial research services in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; basic scientific research and clinical scientific research, hereunder for medicine and vaccine development; product research and development in the field of diagnostic preparations; scientific analysis services in fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; scientific laboratory services; quality control testing and consultancy related thereto; scientific research, testing and analysis services in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; providing scientific technology and methods to others, namely, rental of laboratory apparatus and instruments and scientific research consulting; providing scientific information about industrial analysis and research services in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; development of scientific, chemical and medical products for others for medical and research purposes; development of scientific, chemical and medical products for others in the fields of biochemistry and biotechnology; providing scientific information, advice and consultancy to others in the fields of biochemistry and biotechnology | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 13, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 13, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 14, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 19, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 19, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 17, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 17, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 17, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 1, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 1, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 12, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 23, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 23, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 23, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 23, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 23, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 21, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 3, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 2, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 18, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |